Anti-PD-1 therapy for preventing recurrence and improving survival in hepatocellular carcinoma patients after hepatectomy

Anti-PD-1 therapy for preventing recurrence and improving survival in hepatocellular carcinoma patients after hepatectomy

Abstract Background and aim Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with a high recurrence rate after resection. This study investigates the efficacy of postoperative anti-PD-1 antibody therapy on overall survival (OS) and recurrence-free survival (RF...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiansheng Zhao, Yong Peng, Airong Hu, Suwen Jiang
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Surgery
Subjects:
Hepatocellular carcinoma
Vessels encapsulating tumor cluster
Anti-PD-1 antibodies
Postoperative adjuvant therapy
Online Access:https://doi.org/10.1186/s12893-025-03117-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items